More articles from Other Topics

Abstract A76: Microenginered human lymphoid tissue on chip
Girija Goyal, Jaclyn Long, Donald E. Ingber

Cancer Immunology Research Sep 2018, 6 (9 Supplement) A76; DOI: 10.1158/2326-6074.TUMIMM17-A76
Abstract A78: Analysis of ROR1 protein expression in mice with reconstituted human immune system components
Carol SK Leung

Cancer Immunology Research Sep 2018, 6 (9 Supplement) A78; DOI: 10.1158/2326-6074.TUMIMM17-A78
Abstract A77: Cripto-1 vaccination elicits protective immune response to metastatic breast cancer and breast cancer stem cells
Kristina Witt, Maarten Alexander Ligtenberg, Laura Conti, Stefania Lanzardo, Roberto Ruiu, Helena Tufvesson-Stiller, Jeanette Ostling, Charlotte Rolny, Alvaro Lladser, Andreas Lundqvist, Federica Cavallo, Rolf Kiessling

Cancer Immunology Research Sep 2018, 6 (9 Supplement) A77; DOI: 10.1158/2326-6074.TUMIMM17-A77
Abstract A79: Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of antigen-presenting cells and tumor antigen-specific CTLs
Michael C. Brown, Eda K. Holl, David Boczkowski, Elena Dobrikova, Mubeen Mosaheb, Vidya Chandramohan, Darell D. Bigner, Matthias Gromeier, Smita K. Nair

Cancer Immunology Research Sep 2018, 6 (9 Supplement) A79; DOI: 10.1158/2326-6074.TUMIMM17-A79
Abstract A75: A radiosensitivity gene signature and PD-L1 expression are predictive of the clinical outcomes of patients with lower-grade glioma in The Cancer Genome Atlas dataset
Bum Sup Jang, In Ah Kim

Cancer Immunology Research Sep 2018, 6 (9 Supplement) A75; DOI: 10.1158/2326-6074.TUMIMM17-A75
Abstract B65: Alteration in cholesterol homeostasis and antibody synthesis in B cells an in-vivo effect of carcinogen (polyaromatic)
Nimisha Saxena, Amar Preet Kaur, Nimai Chand Chandra

Cancer Immunology Research Mar 2017, 5 (3 Supplement) B65; DOI: 10.1158/2326-6074.TUMIMM16-B65
Abstract B67: Antibody-mediated delivery of viral peptides selectively activates CD8+ T cells to eliminate tumor cells in vitro and in vivo
Julian Peter Sefrin, Lars Hillringhaus, Valeria Lifke, Alexander Lifke

Cancer Immunology Research Mar 2017, 5 (3 Supplement) B67; DOI: 10.1158/2326-6074.TUMIMM16-B67
Abstract B84: Preclinical analysis of combinatorial glioblastoma therapy with the prodrug-mediated gene therapy vector AdV-TK and immune checkpoint inhibition
Maria Carmela Speranza, Franz Ricklefs, Carmela Passaro, Sarah R. Klein, Kazue Kasai, Johanna Kaufmann, Hiroshi Nakashima, Bronisz Agnieszka, Estuardo Aguilar-Cordova, Brian W. Guzik, Gordon J. Freeman, David A. Reardon, Patrick Wen, E. Antonio Chiocca, Sean E. Lawler

Cancer Immunology Research Mar 2017, 5 (3 Supplement) B84; DOI: 10.1158/2326-6074.TUMIMM16-B84
Abstract B72: Combining immune checkpoint inhibition and DNA damage repair (DDR) targeted therapy in small cell lung cancer (SCLC)
Triparna Sen, Limo Chen, Bertha Leticia Rodriguez, Yongbin Yang, You Hong Fan, Catherine Allison Stewart, Bonnie Glisson, Helen Piwnica-Worms, Julien Sage, John V. Heymach, Don L. Gibbons, Lauren A. Byers

Cancer Immunology Research Mar 2017, 5 (3 Supplement) B72; DOI: 10.1158/2326-6074.TUMIMM16-B72
Abstract B89: The chimeric antibody NZ-12 or CAR T cells targeting human podoplanin possesses antitumor activity against orthotopic xenograft models
Yukinari Kato, Satoshi Shiina, Atsushi Natsume, Shinji Abe, Yasuhiko Nishioka, Satoshi Ogasawara, Mika K. Kaneko

Cancer Immunology Research Mar 2017, 5 (3 Supplement) B89; DOI: 10.1158/2326-6074.TUMIMM16-B89

Main menu

User menu

Search

More articles from Other Topics

Pages

Articles

Info for

About Cancer Immunology Research